NextCure, Inc. — Form D

NextCure, Inc. of BELTSVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-19. The offering totals $93.4M, of which $93.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Elaine N JonesDirectorBeltsville, MD
David KabakoffDirectorBrisbane, CA
Chau Q KhuongDirectorBeltsville, MD
Judith LiDirectorSan Diego, CA
Tim Q ShannonDirectorBeltsville, MD
Stella XuDirectorBeltsville, MD
Michael YiDirectorSouth San Francisco, CA
Steven CobournExecutive OfficerBeltsville, MD
Kevin N HellerExecutive OfficerBeltsville, MD
Timothy G MayerExecutive OfficerBeltsville, MD
Michael RichmanDirectorBeltsville, MD
Michael RichmanExecutive OfficerBeltsville, MD
Udayan G GuhaExecutive OfficerBeltsville, MD
Anne G BorgmanDirectorBeltsville, MD
Steven P CobournExecutive OfficerBeltsville, MD
David P KabakoffDirectorBeltsville, MD
Sourav G KunduExecutive OfficerBeltsville, MD
Ellen G FeigalDirectorBeltsville, MD
Stephen G WebsterDirectorBeltsville, MD
John G HoustonDirectorBeltsville, MD
Kevin G ShawExecutive OfficerBeltsville, MD
Asher RubinExecutive OfficerBaltimore, MD
CAROLYN GREENDirectorGERMANTOWN, MD
JUDITH Q LIDirectorGERMANTOWN, MD
Elaine V JonesDirectorAustin, TX

Other filings by this issuer (2)

FiledFormOfferingSold
2025-12-10D$21.5M$21.5M
2016-01-11D$67.0M$15.0M

More